Skip to main content

Animations

MJFF Publications

3171 - 3180 of 8654 Results
Title
Year
  • Year
  • 2023
  • 2019
  • 2018
  • 2021
  • 2011
  • 2018
  • 2023
  • 2024
  • 2022
  • 2017
  • Summary Details
    OPEN
    Title: The α-synuclein PET tracer [18F] ACI-12589 distinguishes multiple system atrophy from other neurodegenerative diseases
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-023-42305-3
    Citation Count: 64
  • Summary Details
    OPEN
    Title: Cancer outcomes among Parkinson's disease patients with leucine rich repeat kinase 2 mutations, idiopathic Parkinson's disease patients, and nonaffected controls
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27807
    Best OA location URL:
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Phosphorylated α‐synuclein in the retina is a biomarker of Parkinson's disease pathology severity
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27392
    Best OA location URL:
    Citation Count: 139
  • Summary Details
    OPEN
    Title: Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28779
    Citation Count: 135
  • Summary Details
    RESTRICTED
    Title: Retigabine, a KV7 (KCNQ) potassium channel opener, attenuates l-DOPA-induced dyskinesias in 6-OHDA-lesioned rats
    Journal Name: Neuropharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuropharm.2011.10.016
    Best OA location URL:
    Citation Count: 24
  • Summary Details
    OPEN
    Title: Activation of Nrf2 and Hypoxic Adaptive Response Contribute to Neuroprotection Elicited by Phenylhydroxamic Acid Selective HDAC6 Inhibitors
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acschemneuro.7b00435
    Best OA location URL:
    Citation Count: 34
  • Summary Details
    OPEN
    Title: Necroptosis inhibition counteracts neurodegeneration, memory decline, and key hallmarks of aging, promoting brain rejuvenation
    Journal Name: Aging Cell
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1111/acel.13814
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Distinctive CD56dim NK subset profiles and increased NKG2D expression in blood NK cells of Parkinson’s disease patients
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-024-00652-y
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Multiple N-of-1 trials to investigate hypoxia therapy in Parkinson’s disease: study rationale and protocol
    Journal Name: BMC Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12883-022-02770-7
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Reversible Conformational Conversion of α-Synuclein into Toxic Assemblies by Glucosylceramide
    Journal Name: Neuron
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuron.2017.12.012
    Citation Count: 195
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.